SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as it breaks into new all-time high territory, with the community largely focused on the stock's massive institutional momentum and its role as the centerpiece of the ongoing AI infrastructure supercycle. While many investors are celebrating the breakout and discussing aggressive new price targets, others are debating the sustainability of the rally, noting potential divergences in market breadth and questioning the long-term impact of extreme valuations.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing a severe sell-off following the collapse of a key relationship with Marvell, which terminated purchase orders citing a confidentiality breach by management. The community is sharply divided between investors calling for a total leadership overhaul due to the perceived communication failures and those attempting to justify the drop as an overreaction that creates a long-term buying opportunity.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science SA is trending due to significant retail interest surrounding its low-float status, which market participants are actively discussing as a primary catalyst for potential short-squeeze activity. The community is sharply divided, with bulls pointing to the company's molecular farming technology as a long-term play, while bears express skepticism regarding its underlying financials and the risk of being left as 'exit liquidity' in what they label a pump-and-dump scheme.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to successful demonstration flights in New York City and ongoing FAA certification progress, signaling a shift from concept to real-world deployment. While the community is actively debating the stock's long-term execution risk and potential for volatility, many see the recent milestones as a critical step toward the company's 2026 commercial launch goals.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is seeing heightened activity as investors weigh recent reports of revenue growth and operational improvements against ongoing concerns about cash burn and a challenging retail environment. The community remains deeply divided, with some traders focused on potential squeeze setups and the company's long-term turnaround strategy, while others emphasize the stock's significant decline and persistent volatility.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

High-Trend International Group is experiencing extreme volatility and intense community speculation following a parabolic run that has driven significant short-squeeze discussions. Investors are actively debating the sustainability of this momentum, with many highlighting the stock's low float and the ongoing battle between aggressive buying and short-selling interest.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is experiencing significant volatility and trading volume as investors react to bullish institutional accumulation and ongoing speculation regarding potential buyout interest or strategic partnerships for its lead asset, paridiprubart. Community discussions remain polarized between optimistic longs betting on a major acquisition or regulatory breakthrough and vocal skeptics highlighting historical trial delays and the potential for share dilution.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is facing downward pressure as investors react to conservative full-year guidance and concerns surrounding the upcoming transition of its lead product, DefenCath, away from its initial reimbursement status. Despite strong recent revenue and a newly authorized share buyback program, the community remains divided, with long-term holders highlighting the stock's low valuation relative to its pipeline potential and upcoming Phase III trial data for Rezzayo.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is capturing significant attention as investors react to positive Phase 3 clinical trial results for its acne treatment, which met all primary and secondary endpoints in China. The community is actively discussing the stock's potential for acquisition, noting its valuation disparity compared to recent sector buyouts and its strategic positioning in both the MASH and acne markets.

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

Orca is trending due to significant trading volume and momentum, with the community actively debating whether the recent price action indicates a sustained breakout or another pump-and-dump cycle. Traders are closely monitoring the token's circulating supply and potential for short squeezes while discussing its role within the broader Solana DeFi ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's What Key Metrics Tell Us About Park National (PRK) Q1 Earnings

Although the revenue and EPS for Park National (PRK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Park National (PRK) Beats Q1 Earnings and Revenue Estimates

Park National (PRK) delivered earnings and revenue surprises of +15.25% and +3.45%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

First Western (MYFW) Q1 Earnings and Revenues Top Estimates

First Western (MYFW) delivered earnings and revenue surprises of +43.18% and +1.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Peoples Bancorp (PEBO) Q1 Earnings and Revenues Surpass Estimates

Peoples Bancorp (PEBO) delivered earnings and revenue surprises of +2.18% and +0.49%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Park National (PRK) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Park National (PRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Park National (PRK) Upgraded to Strong Buy: Here's What You Should Know

Park National (PRK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Park National (PRK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Park National (PRK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Park National (PRK) Q4 Earnings and Revenues Surpass Estimates

Park National (PRK) delivered earnings and revenue surprises of +5.90% and +2.26%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Park National (PRK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Park National (PRK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Park National (PRK) Beats Q3 Earnings and Revenue Estimates

Park National (PRK) delivered earnings and revenue surprises of +5.13% and +1.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Park National Corp. is a holding company, which engages in the provision of banking and non-banking financial services through its subsidiaries. The company was founded in 1986 and is headquartered in Newark, OH.

PRK
Park National Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PRK News

PRKPark National Corp.